Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | BCL2 | P10415 | 1/20 | 0.43 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL988202 | 1.00 | MAPK1 (0.52) | MAPK1ALDH1A1PKMKDM4EALOX15 | |
| SCHEMBL19664675 | 0.83 | ALDH1A1 (0.46) | MAPK1ALDH1A1PKMKDM4EALOX15 | |
| SCHEMBL12100863 | 0.80 | ALDH1A1 (0.53) | MAPK1ALDH1A1PKMKDM4EMEN1 | |
| SCHEMBL4066871 | 0.79 | MAPK1 (0.56) | MAPK1ALDH1A1KDM4EALOX15RNPEP | |
| SCHEMBL15789780 | 0.79 | ALDH1A1 (0.53) | MAPK1ALDH1A1PKMKDM4EALOX15 | |
| SCHEMBL4594736 | 0.79 | MAPK1 (0.46) | MAPK1ALDH1A1KDM4EALOX15RNPEP | |
| SCHEMBL1226562 | 0.78 | ALDH1A1 (0.54) | MAPK1ALDH1A1PKMKDM4EMEN1 | |
| SCHEMBL1679404 | 0.77 | ALDH1A1 (0.46) | MAPK1ALDH1A1PKMKDM4EMME | |
| SCHEMBL631270 | 0.77 | ALDH1A1 (0.56) | MAPK1ALDH1A1PKMKDM4EALOX15 | |
| SCHEMBL2804782 | 0.77 | ALDH1A1 (0.53) | MAPK1ALDH1A1PKMKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1404356-B1 | METHOD FOR DESIGNING CD10-ACTIVATED PRODRUG COMPOUNDS | MEDAREX INC (US) | 2011-04-06 | — | — | EP | disclosed |
| US-20110020914-A1 | METHODS FOR ENHANCING GROWTH OF ORGANISMS IN AN AQUEOUS GROWTH MEDIUM | NOVUS INTERNATIONAL INC (US) | 2011-01-27 | — | — | US | disclosed |
| US-20070231377-A1 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | NOVUS INTERNATIONAL INC. (US) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070231377-A1 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | FGF1, MTR, HGF | MAPK1 3232/4885ALDH1A1 2239/4885PKM 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.